Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery

<table>Effect of increasing concentration of pore former, chitosan (FC1-15%) (FC4-20%) and (FC7-25%) on<i> in vitro</i> drug release in SCF. Each point represents the mean ± SD.</table>

Journal of Pharmaceutics

fig2

Figure 2

Figure 2: Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery 

Figure 2 | Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery 